Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2025)

Historic Non-Current Deffered Revenue for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to $45.2 million.

  • Cellebrite DI's Non-Current Deffered Revenue fell 393.01% to $45.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $45.2 million, marking a year-over-year decrease of 393.01%. This contributed to the annual value of $45.2 million for FY2024, which is 393.01% down from last year.
  • Per Cellebrite DI's latest filing, its Non-Current Deffered Revenue stood at $45.2 million for Q4 2024, which was down 393.01% from $47.1 million recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's Non-Current Deffered Revenue ranged from a high of $47.1 million in Q4 2023 and a low of $33.4 million during Q4 2020
  • Over the past 5 years, Cellebrite DI's median Non-Current Deffered Revenue value was $39.3 million (recorded in 2021), while the average stood at $39.8 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first surged by 1577.72% in 2022, then crashed by 393.01% in 2024.
  • Over the past 5 years, Cellebrite DI's Non-Current Deffered Revenue (Quarter) stood at $33.4 million in 2020, then increased by 8.93% to $36.4 million in 2021, then rose by 15.78% to $42.2 million in 2022, then increased by 11.68% to $47.1 million in 2023, then decreased by 3.93% to $45.2 million in 2024.
  • Its Non-Current Deffered Revenue was $45.2 million in Q4 2024, compared to $47.1 million in Q4 2023 and $42.2 million in Q4 2022.